接受放射治疗的超中央型I期非小细胞肺癌患者的毒性:LUSTRE随机试验的二次分析
该研究为LUSTRE随机试验的二次分析,纳入233例医学上无法手术的I期NSCLC患者,其中30例为超中央型靶区直接重叠近端支气管树。中位随访2.9年,3例和1例分别发生3级和5级毒性(均为SBRT),3年局部控制率为85%。发生≥3级毒性者的近端支气管树平均剂量更高,尤其4cc和5cc剂量及体积剂量参数。
要点
- 超中央型NSCLC接受SBRT的3-5级晚期毒性发生率较高,本分析中4例(3级3例,5级1例)。
- 3年局部控制率为85%。
- 发生≥3级毒性者的近端支气管树4cc和5cc平均剂量显著高于未发生者。
核心结论
- 超中央型NSCLC的SBRT局部控制良好,但晚期3-5级毒性发生率较高。
- 观察到毒性近端支气管树体积剂量之间存在明显关联,若提供SBRT应考虑此点。
研究设计与样本
- LUSTRE随机试验的二次分析,纳入2014年至2020年招募的233例医学上无法手术的I期NSCLC患者。
- 识别出靶区直接重叠近端支气管树的超中央型患者30例(SBRT 60 Gy/8次23例,常规大分割放疗60 Gy/15次7例)。
- 主要目标为放疗后3个月以上相关3-5级毒性的发生;次要终点包括局部控制、生存及近端支气管树剂量与晚期毒性的关联。
主要发现
- 30例超中央型肿瘤患者中位年龄72岁,中位肿瘤大小2.8 cm,67%患者经组织学确诊NSCLC。
- 中位随访2.9年,3例发生3级毒性、1例发生5级毒性,均为SBRT组。
- 3年局部控制率为85%。
- 发生≥3级毒性者的近端支气管树平均剂量(转换为2 Gy等效剂量)更高:4cc为105.5 Gy vs 51.8 Gy(p=0.0004),5cc为84 Gy vs 46.1 Gy(p=0.003),体积剂量V65-V100Gy亦更高。
- 发生5级毒性者的5cc剂量最高(117 Gy),V90Gy为8.2 cc,V100Gy为7 cc。
关键数值与推荐
- 超中央型靶区定义为直接重叠近端支气管树。
- SBRT方案为60 Gy/8次,常规大分割放疗为60 Gy/15次。
- 主要终点为放疗后3个月以上相关3-5级毒性。
临床怎么用
- 原文结论指出,若提供SBRT应考虑毒性近端支气管树体积剂量之间的明显关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Stereotactic body radiotherapy (SBRT) carries potentially higher risks for ultracentral (UC) NSCLC with limited prospective data to guide decision making. We conducted a secondary analysis from a randomized trial of SBRT and conventionally hypofractionated radiation (CRT) to assess these risks. MATERIALS AND METHODS: Patients (n = 233) with medically inoperable stage I NSCLC were recruited from 2014 to 2020. Patients with UC targets directly overlapping the proximal bronchial tree (PBT) were identified. The primary objective was the occurrence of related grade 3-5 toxicity > 3 months following radiation. Secondary endpoints included local control, survival, and evaluation of PBT dose and its association with late toxicity. RESULTS: Thirty UC tumors were identified (23 - SBRT 60 Gy/8 fractions, 7 - CRT 60 Gy/15 fractions). Median age was 72 years, and median tumor size was 2.8 cm. Most patients (67 %) had histologically confirmed NSCLC. At a median follow-up of 2.9 years, 3 and 1 patients developed grade 3 and 5 toxicity respectively (all SBRT). 3-year local control was 85 %. Mean PBT dose (converted to 2 Gy dose equivalents) was higher in patients with grade ≥ 3 toxicity, particularly for 4 cc (105.5 vs 51.8 Gy, p = 0.0004), 5 cc (84 vs 46.1 Gy, p = 0.003), and volumetric doses (V65 - V100Gy). The patient with grade 5 toxicity had the highest 5 cc dose (117 Gy), V90Gy (8.2 cc), and V100Gy (7 cc). CONCLUSIONS: SBRT for UC NSCLC provides good local control but carries a high rate of late grade 3-5 toxicity. An apparent association between toxicity and PBT volumetric dose was observed, which should be considered if SBRT is offered.
引用
- Wu CHD, Wierzbicki M, Parpia S, et al. Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial. Radiother Oncol. 2024. PMID: 39481606. doi:10.1016/j.radonc.2024.110605
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。